There are 2789 resources available
896P - Long-responders to ICI in R/M-HNSCC: A retrospective multicentric French cohort
Presenter: Matthieu Lasserre
Session: ePoster Display
897P - Genomic alterations in smokers with oropharyngeal squamous cell cancer (OSCC) determined by targeted next generation sequencing
Presenter: Panagiota Economopoulou
Session: ePoster Display
926TiP - Phase II trial of enoblituzumab plus retifanlimab or tebotelimab in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M SCCHN)
Presenter: Grzegorz Obara
Session: ePoster Display
928TiP - Induction versus adjuvant gemcitabine/cisplatin in locally advanced non-metastatic nasopharyngeal carcinoma: A randomised phase III trial
Presenter: Shereen Masoud
Session: ePoster Display
929TiP - HERODOTUS: Head and neck cancers international COVID-19 collaboration: An international registry on head and neck cancer with COVID-19
Presenter: Amanda Psyrri
Session: ePoster Display
930TiP - innovaTV 207: New dosing cohort in the open label phase II study of tisotumab vedotin in solid tumors
Presenter: David Hong
Session: ePoster Display
906P - Simlukafusp α and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck
Presenter: Aaron Hansen
Session: ePoster Display
907P - Ribociclib and spartalizumab for head and neck squamous cell carcinoma: A phase I study with expansion cohort
Presenter: Hsiang-Fong Kao
Session: ePoster Display